| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |